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1  | INTRODUC TION
The rapid worldwide spread of severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) has caused an unparalleled crisis and 
requires urgent testing of prophylactic and therapeutic measures. 
SARS-CoV-2 likely emerged from a yet unknown animal reservoir; its 
rapid spread can be attributed to efficient replication in the upper re-
spiratory tract and robust human-to-human transmission. This char-
acteristic clearly distinguishes this novel coronavirus from the related 
SARS-CoV-1 and MERS-CoV (Andersen et al., 2020). Interestingly, 
SARS-CoV-2 human-to-animal transmissions have also been reported 
(Halfmann et al., 2020; Leroy et al., 2020). Currently, we find ourselves 
racing for efficacious therapies and protective vaccinations. In this 
context, small animal models are indispensable as pre-clinical studies 
in animals are of critical importance for basic and applied research 
on SARS-CoV-2 infection. Several SARS-CoV-2 animal models have 
been investigated, including non-human primates, ferrets, transgenic 
mice, cats and hamsters, (Chan et al., 2020; Dhama et al., 2020; Imai 
et al., 2020; Lakdawala & Menachery, 2020; Osterrieder et al., 2020; 
Sia et al., 2020; Trimpert et al., 2020; Yuan et al., 2020). However, in sil-
ico models with respect to potential usage of the entry receptor by the 
spike glycoprotein (S) of SARS-CoV-2 suggest susceptibility of Chinese 
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The SARS-CoV-2 pandemic has caused a yet unresolved global crisis. Effective 
medical intervention by vaccination or therapy seems to be the only possibility to 
control the pandemic. In this context, animal models are an indispensable tool for 
basic and applied research to combat SARS-CoV-2 infection. Here, we established a 
SARS-CoV-2 infection model in Chinese hamsters suitable for studying pathogenesis 
of the disease as well as pre-clinical testing of vaccines and therapies. This species 
of hamster is susceptible to SARS-CoV-2 infection as demonstrated by robust virus 
replication in the upper and lower respiratory tract accompanied by bronchitis and 
pneumonia as well as significant body weight loss following infection. The Chinese 
hamster features advantages compared to the Syrian hamster model, including more 
pronounced clinical symptoms, its small size, well-characterized genome, transcrip-
tome and translatome data and availability of molecular tools.
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hamsters (Cricetulus griseus) (Luan et al., 2020; Luan et al., 2020) and 
a previous study in Chinese hamsters demonstrated susceptibility to 
SARS-CoV-1 (Luo et al., 2007). We here determined SARS-CoV-2 sus-
ceptibility of Chinese hamsters and established this species as novel 
small animal model for SARS-CoV-2 research.
2  | MATERIAL S AND METHODS
2.1 | Viruses and cells
The SARS-CoV-2 München isolate (BetaCoV/Germany/
BavPat1/2020) (Wölfel et al., 2020) was used for virus challenge. 
Stocks were propagated and titrated on Vero E6 cells (ATCC CRL-
1586) in minimal essential medium (MEM; PAN Biotech, Aidenbach, 
Germany) supplemented with 10% foetal bovine serum (PAN 
Biotech), 100 IU/ml penicillin G and 100 µg/ml streptomycin (Carl 
Roth, Karlsruhe, Germany) and stored at −80°C prior to experimen-
tal infections.
2.2 | Experimental infection of Chinese hamsters
24 five- to seven-week-old female and male Chinese hamsters 
(Cricetulus griseus) were obtained via the German pet trade and kept 
in groups of six animals in enriched, individually ventilated cages. The 
hamsters had ad libidum access to food and water, and were allowed 
acclimatization to these conditions for seven days prior to SARS-CoV-2 
infection. Cage temperatures and relative humidities were recorded 
daily and ranged from 23 to 24°C and from 50% to 65%, respectively. 
The animals were randomly distributed into two groups: SARS-CoV-
2-infected (n = 12; 1 × 105 plaque-forming units (pfu) in a volume of 
30 µl) and mock-infected (n = 12; 30 µl cell culture supernatant from 
uninfected Vero E6 cells). The infection was performed exactly as pre-
viously described (Osterrieder et al., 2020). Baseline body weights of all 
hamsters and body temperatures of at least three hamsters per group 
were measured before infection and then recorded daily throughout 
the 14-day experiment. Moreover, clinical signs of all animals were 
monitored twice daily throughout the experiment. On days 2, 3, 5 
and 14 post-infection (dpi), three randomly assigned hamsters of each 
group were euthanized by exsanguination under general anaesthesia 
as described (Nakamura et al., 2017). For virus titrations and RT-qPCR 
and/or histopathological examinations, blood, bucco-laryngeal swabs 
and lungs (left and right) were collected.
2.3 | Histopathology and in situ hybridization
For histopathology, lungs were processed as previously described 
(Osterrieder et al., 2020). In brief, the left lung lobe was carefully re-
moved and immersion fixed in buffered 4% formalin, pH 7.0, for 48 hr, 
embedded in paraffin and cut at 2 μm thickness. Sections were stained 
with haematoxylin and eosin (HE) followed by blinded microscopic 
evaluation by board certified veterinary pathologists (K.D., A.D.G.). 
For in situ hybridization (ISH), the ViewRNA™ ISH Tissue Assay Kit 
(Invitrogen by Thermo Fisher Scientific, Darmstadt, Germany) was used 
following the manufacturer's instructions with minor adjustments. A 
probe for the detection of the N gene RNA of SARS-CoV-2 (NCBI data-
base NC_045512.2, nucleotides 28,274–29,533, assay ID: VPNKRHM) 
was employed. Next, lung sections of 2 μm thickness were mounted 
on adhesive glass slides, dewaxed in xylol and dehydrated in graded 
ethanols. Tissues were incubated at 95°C for 10 min, and subsequently, 
protease digested for 20 min. Sections were fixed with 4% paraform-
aldehyde dissolved in phosphate-buffered saline (PBS) and hybridized 
with the probes. Amplifier and label probe hybridizations were per-
formed according to the manufacturer's instructions using fast red as 
chromogen. Sections were counterstained with haematoxylin for 45 s, 
washed in tap water for 5 min and mounted with Roti®-Mount Fluor-
Care DAPI (4, 6-diaminidino-2-phenylindole; Carl Roth). For negative 
and morphologically intact controls, lungs from uninfected hamsters 
were included. An irrelevant probe for the detection of streptococ-
cal pneumolysin was used as a control for sequence-specific binding. 
HE-stained and ISH slides were analysed and photographs were taken 
using an Olympus BX41 microscope with a DP80 Microscope Digital 
Camera and the cellSens™ Imaging Software, Version 1.18 (Olympus 
Corporation, Münster, Germany). For overviews, slides were automati-
cally digitized using the Aperio CS2 slide scanner (Leica Biosystems 
Imaging Inc., Vista, CA, USA) followed by image file generation using 
the Image Scope Software (Leica Biosystems Imaging Inc.).
2.4 | Virus titrations, RNA extractions and RT-qPCR
Virus titres from 50 mg lung tissue were assessed by serial dilution 
of tissue homogenates and subsequent titrations on Vero E6 cells. 3 
dpi, cells were formalin-fixed, stained with crystal violet, and plaques 
were counted. RNA was extracted from tissue samples, blood and 
tracheal swabs using the innuPREP Virus RNA kit (Analytic Jena, 
Jena, Germany) and quantified with a one-step RT-qPCR reaction 
(NEB Luna Universal Probe One-Step RT-qPCR kit; New England 
Biolabs, Ipswitch, MA, USA) and previously published TaqMan prim-
ers and probe (Corman et al., 2020).
2.5 | Statistical analyses
Data were analysed with GraphPad PRISM. We used Mann–Whitney 
U tests to compare body weights and body temperatures in mock-
infected versus SARS-CoV-2 infected Chinese hamsters. Data were 
considered significant if p < .05 (*p < .05; **p < .01).
3  | RESULTS AND DISCUSSION
The study, which was approved by the Landesamt für Gesundheit 
und Soziales in Berlin, Germany (permit # 0086/20), involved 24 
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female and male Chinese hamsters of 5–7 weeks of age. Hamsters 
were randomly assigned to two groups (SARS-CoV-2-infected, 
n = 12; mock-infected, n = 12) Upon intranasal infection with 
1x105 plaque-forming units (pfu) of a human SARS-CoV-2 isolate, 
we observed clinical symptoms including transient but significant 
body weight loss and subtle drops in body temperatures at early 
time points after infection, a course of disease comparable to that 
in Syrian hamsters (Figure 1) (Chan et al., 2020; Imai et al., 2020; 
Kreye et al., 2020; Osterrieder et al., 2020; Sia et al., 2020). 
Differences in body weights between infected and mock-infected 
animals were significant at 1–3 and at 5 days post-infection (dpi), 
infected hamsters did not reach pre-infection body weights be-
fore 14 dpi when the experiment was terminated (Figure 1a). 
However, the largest difference in mean body temperatures of in-
fected compared to mock-infected animals was only −0.6°C at 3 
dpi (Figure 1b), suggesting that this parameter may not be useful 
to assess the status of infection. We determined virus replication 
and virus spread by measuring RNA copy numbers in the lungs, 
bucco-laryngeal swabs and whole blood samples of all hamsters 
(Figure 1c–e).
F I G U R E  1   Body weight changes, 
body temperatures and virus loads of 
mock-infected and SARS-CoV-2-infected 
Chinese hamsters. (a) Individual relative 
body weights of mock-infected (green) 
and SARS-CoV-2-infected (red) hamsters 
over the course of 14 days after infection. 
p-values indicate significant differences 
(Mann–Whitney U test). (b) Temperature 
changes (as means with SD). Virus loads 
were determined from total RNA in (c) 
2.5 mg homogenized right cranial lung 
lobes, in (d) bucco-laryngeal swabs and 
(e) 2.5 µl of whole blood samples by 
RT-qPCR [Colour figure can be viewed at 
wileyonlinelibrary.com]
F I G U R E  2   Histopathological assessment of mock-infected and SARS-CoV-2-infected Chinese hamsters. Histopathology of 
haematoxylin–eosin-stained lung sections from SARS-CoV-2-infected Chinese hamsters revealed suppurative bronchitis (a, b; arrow: 
neutrophils) and necrosuppurative pneumonia (c, d) at 2 and 3 dpi. At 5 dpi (e, f), additional hyperplasia of alveolar epithelial cells (AEC)-
type II was salient (f, arrow). Tissue damage, cell influx and hyperplasia of AEC-II (h, arrow) were milder but still present at 14 dpi (g, h). 
Of note, acute alveolar damage (I, arrows) was multifocally distributed throughout the lungs across all time points investigated. None of 
these lesions was detected in mock-infected animals (j, k). Bars: 1 mm (a, c, e, g, j) or 50 µm (b, d, f, h, i, k) [Colour figure can be viewed at 
wileyonlinelibrary.com]
(a) (b) (c) (d) (e) (f)
(g) (h) (i) (j) (k)
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In addition, we determined viral titres in the lungs of infected 
animals (Figure S1). Our assays confirmed high RNA copy num-
bers and corresponding viral titres at early time points after in-
fection followed by a rapid but incomplete clearance of the virus 
infection until 14 dpi. With titres of up to 5 × 107 pfu per 50 mg 
lung tissue and viral RNA copies in the range of up to 1 × 107 per 
2.5 mg lung tissue at early time points after infection, we con-
cluded that Chinese hamsters are highly susceptible to SARS-
CoV-2. On the other hand, virus loads in blood samples were 
below 1 × 102 RNA copies per 2.5 µl of whole blood (15.6 ± 29.8 
SD) at all time points, indicating lack of significant viremia and 
systemic infection (Figure 1e). These observations match find-
ings from other animal models for emerging coronaviruses (Yuan 
et al., 2020).
Lung histopathology revealed tissue damage and inflammation 
principally similar to what has been described in Syrian hamsters 
(Figure 2) (Chan et al., 2020; Gruber et al., 2020; Imai et al., 2020; 
Kreye et al., 2020; Osterrieder et al., 2020; Sia et al., 2020). However, 
the course of bronchitis and pneumonia was in general milder than 
in Syrian hamsters, and pneumonia was more prolonged. Specifically, 
prominent acute alveolar damage was present until 14 dpi with per-
sistence of viral RNA (Figures 1c, 2g-i and S2), indicating overall 
slower recovery than described for Syrian hamsters. Similarly, viral 
RNA was localized by in situ hybridization to bronchial epithelial 
cells, alveolar epithelial cells type-I and type-II and alveolar macro-
phages (Figure S2, arrows).
In agreement with the clinical course of disease, virological and 
histopathological results confirm that this animal model withstands 
the comparison with the Syrian hamster model with the advantage of 
a prolonged period of significantly reduced body weights following 
infection with SARS-CoV-2. Moreover, the considerably smaller size 
of the Chinese hamster offers an important practical advantage when 
compared to the rather large Syrian hamster and allows husbandry 
in smaller cages and lager groups. Additionally, the Chinese hamster 
genome, transcriptome and translatome are well characterized and a 
variety of molecular tools is available for this species as Chinese ham-
ster ovary (CHO) cells are widely used in biopharmaceutical research 
and industry (Matasci et al., 2008; Walsh, 2018). At the same time, 
the usefulness of any model depends on fundamental knowledge of 
species-specific similarities to and differences from the human dis-
ease, as well as other confounding factors, including age and comor-
bidities (Metersky & Waterer, 2020). Because of the heterogeneous 
disease phenotype in humans, there is a need for different SARS-
CoV-2 animal models that allow evaluation of vaccines and antiviral 
therapies for different subsets of the human population.
Taken together, our results suggest the suitability of the Chinese 
hamster small animal model to study SARS-CoV-2 infections, with 
body weight losses as a robust clinical disease parameter. As an es-
tablished model for SARS-CoV-1 infection, the Chinese hamster may 
also allow comparison between experimental coronavirus infections. 
Moreover, our findings highlight the possibility of comparing, in future 
studies, the effects of preventive as well as therapeutic measures to 
restrain infection and viral replication in different animal models.
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